Risk Profiling and Precision Heart Health Driven by AI-Enabled CV Imaging (Cleerly)
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Equity/Stock(s)/Options (Personal) - Cleerly, Inc.
- Medical Advisory Board (Personal) - Arineta